Stocks in focus: PSUs, IT and pharma see key triggers

Markets may see stock-specific action as Tata Sons defers a key leadership decision, POWERGRID gets investment clearance, railway and defence-linked firms secure orders, and pharma companies receive regulatory updates from US authorities.

Tata group stocks will remain in focus as the board of Tata Sons, the holding company of Tata group companies, has deferred, on his recommendation, the decision to reappoint Tata Sons’ Chairman N Chandrasekaran for a third term after some board members, including Noel Tata, expressed reservations. “I recommended that it should be deferred, because of a request from some directors,” Chandrasekaran told the media, while leaving Bombay House after the meeting.

IT, tech stocks

Meta Infotech Ltd has received a renewal order from one of the financial services sector entities (Domestic Company) amounting to Rs 2.46 crore (excluding GST) for subscription of licenses for endpoint protection and cloud workload security for the period from February 20, 2026, to February 19, 2027.

KFin Technologies, a Central Record Keeping Agency (CRA) under the National Pension System (NPS), is enabling instant withdrawal under the NPS Swasthya Scheme. This solution is being developed in collaboration with Apollo 24/7 and is available as a payment option on the Apollo 24/7 Payment App or portal. Subscribers can link their NPS Swasthya account with the Apollo 24/7 Payment app and pay for medical expenses as fast as making a UPI payment. Under this Scheme, subscribers can pay eligible medical expenses from their NPS Swasthya contributions, while their remaining retirement corpus continues to be invested for the future. This helps individuals deal with real-life healthcare needs while maintaining financial discipline for retirement.

Kaynes Semicon Pvt. Ltd., a flagship OSAT (Outsourced Semiconductor Assembly and Testing) initiative of Kaynes Technology India Ltd., has announced its strategic adoption of Synopsys’ engineering simulation software through the Ansys Channel Partner program with Infinipoint Technologies, an Ansys Elite Channel Partner who delivers advanced engineering, simulation, and electronic design solutions. In India’s rapidly evolving semiconductor ecosystem, the implementation will boost its manufacturing quality, reliability, and technological leadership.

PSUs in focus

The Cabinet Committee on Economic Affairs on Tuesday approved an enhancement in the permissible equity investment limit of POWERGRID, enabling the state-run transmission major to participate in capital-intensive projects critical for evacuating renewable energy (RE). Powergrid’s equity investment ceiling per subsidiary has been raised from Rs 5,000 crore to Rs 7,500 crore, capped at 15% of the company’s net worth. The move is expected to enable the company to bid for large transmission projects such as Ultra High Voltage Alternating Current (UHVAC) and High Voltage Direct Current (HVDC) networks, which require substantial upfront capital.

Rail Vikas Nigam Ltd has received LOA worth Rs 270.22 crore from Central Railway for “Design, Supply, Erection, Testing & Commissioning of 220/132/55 KV Traction Substation, Sectioning post (SPs) and Sub sectioning post (SSPs) in 2 x 25 KV Traction System (Scott Connected Transformer) of Daund - Solapur Sections of Central Railway, to meet 3000 MT loading target on EPC mode.

The Union Government, through the Ministry of Railways, has announced an Offer for Sale of up to 26.137 crore shares of Indian Railway Finance Corporation Ltd, representing 2 per cent of its paid-up capital. The Centre has decided to sell an additional 2 per cent in the event of over-subscription, bringing the total to 4 per cent of the company’s equity. The floor price for the offer has been fixed as ₹104.

Old economy stocks

Great Eastern Shipping Company Ltdtook delivery of the 2013 South Korean-built Medium Range Tanker “Jag Pranesh” of about 51,565 dwt on February 24, 2026. The company had contracted to buy the vessel in Q3 FY26. This vessel is financed entirely from internal accruals. After this transaction, the company’s current owned fleet stands at 41 vessels, comprising 27 Tankers (5 Crude Tankers, 17 Product Tankers, 5 LPG Carriers) and 14 Dry Bulk Carriers (2 Capesize, 9 Kamsarmax, 1 Ultramax, 2 Supramax) aggregating 3.25 mn dwt. The Company’s current capacity utilisation is close to 100%.

The Ministry of Food Processing Industries (MoFPI), Government of India, has sanctioned incentives aggregating to ₹33.87 crores to Foods and Inns Ltd for FY’25 under the Production Linked Incentive (PLI) Scheme for the food processing sector. The sanctioned incentive pertains to eligible investments, sales performance, and operational milestones achieved by the Company during FY’25, in accordance with the terms and conditions of the PLI Scheme. The Company had completed all requisite compliances and documentation within the prescribed timelines.

Sunita Tools has entered into an Interim Sales Agreement for 2,40,000 empty NATO Spec & Standard 155mm M107 artillery shells, at the supply rate of 10,000 units per month. It has to be supplied in 24 months, with some grace period. Payment terms are a 50% advance on 3 months’ supply, with monthly supplies paid before delivery, with the advance adjusted that month. Approximately monthly billing of Rs 24 crore will start after all formalities are completed and the advance is received.

Inox Air Products Private Limited (INOXAP), one of India’s leading manufacturers of industrial and medical gases, has entered into a long-term partnership with TACC Limited (The Advanced Carbons Company) (TACC) (Wholly Owned Subsidiary of HEG Limited), for the supply of Nitrogen through a dedicated onsite Nitrogen plant for their upcoming greenfield manufacturing facility in Dewas, Madhya Pradesh, India, for the production of lithium-ion battery-grade graphite anode material. INOXAP will set up the Nitrogen plant on a Build, Own and Operate basis, ensuring a consistent, safe and high-purity nitrogen supply aligned with TACC’s manufacturing needs.

Pharma stocks

Lupin has received approval from the US drug regulator for Brivaracetam Oral Solution 10 mg/mL, indicated for treating partial-onset seizures in patients aged one month and above. The drug is bioequivalent to Briviact Oral Solution of UCB, and Lupin has commenced its US launch. The reference drug recorded estimated annual sales of $135 million in the US, according to IQVIA MAT December 2025 data.

Dr Reddy’s Laboratories Ltd informed the exchanges that it has received a communication from the US Securities and Exchange Commission (SEC) stating that the regulator has concluded its probe into alleged improper payments and does not intend to recommend enforcement action at this time.

Published on February 25, 2026